Ampion is directly administered by inhalation and it allows the drug to directly target and attenuate inflammation in the lungs
Assam is home to more than 1,700 species of medicinal plants
Surufatinib is the third potential new medicine discovered by the company to enter into clinical development in Japan
The company said in a regulatory filing that it was confident of addressing the observations satisfactorily
The CASPIAN Phase III trial in extensive-stage small-cell lung cancer is the longest survival follow-up ever reported for immunotherapy treatment in this setting
The approval will enable the treatment of patients in India living with Essential tremor, tremor-dominant Parkinson's Disease and neuropathic pain
The country’s vaccine production has more than doubled since April and is set to touch 300 million doses next month
If approved, Gavreto will be the first and only targeted treatment approved by the EMA that includes first-line treatment of people with RET fusion-positive advanced NSCLC
The medicine helps restore the balance of certain natural substances (serotonin) in the brain
This award is open to all currently operational laboratories pertaining to testing, calibration & medical including their proficiency testing providers & reference material producers located in India
Subscribe To Our Newsletter & Stay Updated
